About
Technology
Issues
FAQ
Links
Official Page
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.